IL-1β-associated inflammation, lipid metabolic alterations and epithelial barrier injury in necrotizing enterocolitis: partial protection by fenofibrate
Frontiers in Physiology · 10.11.2026 · 17
DOI: 10.3389/fphys.2026.1979880 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Physiology, online erschienen am 10.11.2026. Verfasst von Yinghui Zhang und 3 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Necrotizing enterocolitis (NEC) is characterized by exaggerated inflammation and epithelial barrier injury, but the relationship between inflammatory signaling and intestinal lipid-metabolic dysfunction remains incompletely defined.
Methods
We integrated analysis of the human intestinal transcriptomic dataset GSE46619 with experiments in rat IEC-6 cells and a neonatal mouse NEC model. IEC-6 cells were challenged with LPS or recombinant IL-1β and treated with Il1b siRNA or fenofibrate. In vivo , male and female C57BL/6 neonatal mice underwent formula-feeding/hypoxia exposure from postnatal day 7 to 10 after AAV9-shIl1b or control-vector administration on postnatal day 2; a separate NEC group received fenofibrate.
Results
Human NEC samples showed increased inflammatory signatures and lower fatty-acid-metabolism GSVA scores, with an inverse association between IL1B expression and the fatty-acid-metabolism score. In IEC-6 cells and mouse ileum, inflammatory or NEC-like injury was accompanied by reduced tight-junction and PPARα/CPT1A-associated markers and increased lipid-peroxidation/lipid-content indices. Il1b knockdown and fenofibrate each partially attenuated these abnormalities and improved histological injury in vivo .
Discussion
These findings support a working model linking IL-1β-associated inflammation, lipid metabolic alterations, and epithelial barrier injury in experimental NEC. Because fatty-acid oxidation flux and PPARα loss-of-function were not tested, the data do not establish a direct IL-1β-PPARα causal pathway or strict PPARα dependency.
Zitieren
APA
Zhang, Y., Zhou, Y., Yu, R., & Mei, Y. (2026). IL-1β-associated inflammation, lipid metabolic alterations and epithelial barrier injury in necrotizing enterocolitis: partial protection by fenofibrate. Frontiers in Physiology, 17. https://doi.org/10.3389/fphys.2026.1979880
Vancouver
Zhang Y, Zhou Y, Yu R, Mei Y. IL-1β-associated inflammation, lipid metabolic alterations and epithelial barrier injury in necrotizing enterocolitis: partial protection by fenofibrate. Frontiers in Physiology. 2026;17. doi:10.3389/fphys.2026.1979880
BibTeX
@article{Zhang2026,
author = {Zhang, Yinghui and Zhou, Yahui and Yu, Renqiang and Mei, Yingzi},
title = {IL-1β-associated inflammation, lipid metabolic alterations and epithelial barrier injury in necrotizing enterocolitis: partial protection by fenofibrate},
journal = {Frontiers in Physiology},
year = {2026},
volume = {17},
doi = {10.3389/fphys.2026.1979880}
}
EUVIMED